Skip to content

Clinical trials

Phase 2 Lupus Nephritis trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Nephritis Phase: Phase 2 Country / region: United Kingdom Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20151
20161
20181
20191
20211
20223
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated4
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Alexion Pharmaceuticals, Inc.2
Boehringer Ingelheim2
AstraZeneca1
Autolus Limited1
Bristol-Myers Squibb1
Hoffmann-La Roche1
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1
Teva Branded Pharmaceutical Products R&D, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Nephritis13
Lupus Erythematosus, Systemic5
Glomerulonephritis, IGA2
Glomerulonephritis1
Nephritis1
Proteinuria1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.